LAKE FOREST, Calif., February 26, 2025--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL ...
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICLtm) for vision correction, today announced a leadership transition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback